Metlifecare (ASX:MEQ) EBITDA Margin %: -123.66% (As of Jun. 2020)


What is Metlifecare EBITDA Margin %?

Metlifecare ASX:MEQ 4 EBITDA Margin % is -123.66% as of Jun. 2020. GuruFocus rates ASX:MEQ with a GF Score™ of 4/100. The stock has 8 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Metlifecare's EBITDA for the six months ended in Jun. 2020 was A$-79.39 Mil. Metlifecare's Revenue for the six months ended in Jun. 2020 was A$64.20 Mil. Therefore, Metlifecare's EBITDA margin for the quarter that ended in Jun. 2020 was -123.66%.

Metlifecare  (ASX:MEQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Metlifecare EBITDA Margin % Related Terms

Metlifecare EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Metlifecare's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metlifecare EBITDA Margin % Chart

Metlifecare Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 232.45 251.47 128.21 43.33 -38.06

Metlifecare Semi-Annual Data
Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.00 0.00 0.00 52.03 -123.66

ASX:MEQ vs HCA, DVA, UHS: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, Metlifecare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metlifecare EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Metlifecare's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Metlifecare's EBITDA Margin % falls into.


Metlifecare EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Metlifecare's EBITDA Margin % for the fiscal year that ended in Jun. 2020 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2020 )/Revenue (A: Jun. 2020 )
=-47.648/125.193
=-38.06 %

Metlifecare's EBITDA Margin % for the quarter that ended in Jun. 2020 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2020 )/Revenue (Q: Jun. 2020 )
=-79.386/64.196
=-123.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -123.66% mean?
Metlifecare (ASX:MEQ) has a EBITDA Margin % of -123.66% as of Jun. 2020. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Metlifecare and its competitors.
Is Metlifecare's EBITDA Margin % too high?
Metlifecare's current EBITDA Margin % is -123.66%. Overall, Metlifecare has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metlifecare's EBITDA Margin % compare to HCA and DVA?
Metlifecare's EBITDA Margin % of -123.66% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Metlifecare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metlifecare's current EBITDA Margin % is -123.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metlifecare stock overvalued right now?
Metlifecare (ASX:MEQ) has a current EBITDA Margin % of -123.66%. The current EBITDA Margin % is -123.66%. Metlifecare's overall GF Score™ is 4/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Metlifecare (ASX:MEQ), the current EBITDA Margin % is -123.66% as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metlifecare Business Description

Address 20 Kent Street, Level 4, Newmarket, Auckland, NTL, NZL, 1023
Metlifecare Ltd operates retirement communities throughout New Zealand. It generates revenue from membership fees and rest home, hospital and service, and village fees. Metlifecare's membership fees are paid by residents of independent living units and serviced apartments and allow residents to use common facilities. Its largest single customer is the New Zealand government, which pays fees on behalf of residents eligible for government subsidized elderly care. The majority of Metlifecare's retirement villages are located in Auckland.